Lv1
10 积分 2024-09-05 加入
Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE
12小时前
待确认
Hederacolchiside A1 suppresses proliferation of tumor cells by inducing apoptosis through modulating PI3K/Akt/mTOR signaling pathway
11天前
已完结
Clinical role of radiofrequency ablation for early‐stage hepatocellular carcinoma in an advanced aging society
18天前
已完结
[The efficacy and safety of computed tomography-guided percutaneous cryoablation for malignant liver tumors at high-risk sites]
1个月前
已完结
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience
1个月前
已完结
Therapeutic analysis of 632 cases treated by transcatheter arterial chemoembolization combined with ablation in hepatocellular carcinoma: A retrospective study
1个月前
已完结
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching
1个月前
已完结
FRI-397 A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
1个月前
已完结
Machine-learning–based plasma metabolomic profiles for predicting long-term complications of cirrhosis
1个月前
已完结
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
